Latest news with #VisionAI
Yahoo
a day ago
- Business
- Yahoo
SoundHound AI (SOUN) Unveils Vision AI As Sales Soar US$71 Million
SoundHound AI recently advanced its technological arsenal with the launch of Vision AI, which integrates visual understanding with its voice-first platform, and reported improved earnings with sales growing over the year. The company's optimistic earnings outlook came alongside a significant 19% share price increase last quarter. This move occurred as the broader market, represented by tech-focused indexes like Nasdaq, also experienced gains, reaching new highs. While some of SoundHound's developments added weight to broader market moves, factors like company growth in sales and enhanced business strategies played a role without countering market trends. We've identified 3 warning signs with SoundHound AI and understanding the impact should be part of your investment process. Find companies with promising cash flow potential yet trading below their fair value. The launch of Vision AI by SoundHound AI is enhancing its voice-first platform, aiming to integrate visual understanding and expand its technological reach. This development, viewed in conjunction with the company's growth in sales and improved earnings, reinforces its strategic positioning in the voice AI market. Over the past three years, SoundHound's total shareholder returns surged a very large 200.28%, illustrating significant gains. This longer-term performance contrasts with the past year, where SoundHound's return outpaced both the broader US market and the US Software industry, which had returns of 19.9% and 34.7% respectively. The introduction of Vision AI is expected to bolster SoundHound's revenue and earnings forecasts by creating additional revenue streams, especially within the emerging voice commerce sector. The company plans to strengthen its competitive advantage and revenue growth through diversified customer bases and increased royalties. However, the current share price remains close to the analyst consensus price target of US$11.81, suggesting limited anticipated upside based on perceived fair value. Investors might interpret this narrow gap as alignment with market expectations for near-term performance but should continuously reassess based on evolving market conditions and company developments. Take a closer look at SoundHound AI's potential here in our financial health report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SOUN. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio


Business Wire
2 days ago
- Automotive
- Business Wire
SoundHound Launches Vision AI, Bringing Real-Time Visual Understanding to its Conversational AI Platform
SANTA CLARA, Calif.--(BUSINESS WIRE)--SoundHound AI, Inc. (NASDAQ: SOUN), a global leader in voice AI and conversational intelligence, today announced the launch of Vision AI – an advanced visual understanding engine natively integrated with SoundHound's voice-first platform. This innovation will enable any enterprise to deliver empathetic, context-aware interactions that feel more human—whether it's in a car, a drive-thru, on the retail floor, or in industrial operations. Inspired by how the human brain processes spoken language and visual context in harmony, Vision AI unites voice and visual capabilities into one intelligent platform, allowing the technology to listen, see, and interpret the world around it with remarkable clarity. Importantly, this innovation will enable any enterprise to deliver empathetic, context-aware interactions that feel more human—whether it's in a car, a drive-thru, on the retail floor, or in industrial operations. 'At SoundHound, we believe the future of AI isn't just multimodal – it's deeply integrated, responsive, and built for real-world impact,' said Keyvan Mohajer, CEO of SoundHound AI. 'With Vision AI, we're extending our leadership in voice and conversational AI to redefine how humans interact with products and services offered and used by businesses.' Vision AI works by uniting camera-enabled visual perception with SoundHound's Polaris automatic speech recognition, natural language understanding, agent orchestration, and text-to-speech technologies. The technology has been designed to meet the demanding needs of enterprise applications. By fusing visual cues with live audio and language understanding in real-time, the system enables use cases such as: Hands-free equipment troubleshooting AI-powered retail inventory intelligence In-car discovery agents Personalized drive-thru experiences 'With Vision AI, we are fusing visual recognition and conversational intelligence into a single, synchronized flow. Every frame, every utterance, every intent is interpreted within the same ecosystem – ensuring faster, more natural user experiences that scale across surfaces from kiosks to embedded devices,' said Pranav Singh, VP of Engineering at SoundHound AI. 'This is innovation at the intersection of intelligence and execution, delivering AI that sees what you see, hears what you say, and responds in the moment.' A New Interaction Paradigm for Enterprises The introduction of Vision AI empowers SoundHound's partners to: Deliver faster, frictionless user interactions Unlock operational efficiencies by eliminating manual inputs like typing or scanning Enable scalable deployments across mobile, automotive, kiosk, and embedded environments Deploy ground intelligent agents in real-world visual context Fully integrated with SoundHound's end-to-end proprietary conversational AI stack, Vision AI offers domain-customizable visual understanding, continuous learning loops, and unmatched deployment flexibility. Learn more about Vision AI here. Furthering our Agentic Momentum with Amelia 7.1 This month, SoundHound AI also launched Amelia 7.1. This update advances our agentic AI platform with major increases in speed and conversational responsiveness, AI agent accuracy (with enhanced knowledge matching and fine-tuning), greater transparency with full agent data logs, and better user experience with new UI visualizations—delivering more accurate agents, faster conversations, and expanded enterprise control. Learn more about the Amelia platform here. About SoundHound AI SoundHound AI (Nasdaq: SOUN), a global leader in voice and conversational intelligence, delivers AI solutions that allow businesses to offer superior experiences to their customers. Built on proprietary technology, SoundHound's voice AI delivers best-in-class speed and accuracy in numerous languages to product creators and service providers across retail, financial services, healthcare, automotive, smart devices, and restaurants. The company's various groundbreaking AI-driven products include Smart Answering, Smart Ordering, Dynamic Drive-Thru, and the Amelia Platform, which powers AI Agents for enterprise. In addition, SoundHound Chat AI, a powerful voice assistant with integrated Generative AI, and Autonomics, a category-leading operations platform that automates IT processes, have allowed SoundHound to power millions of products and services, and process billions of interactions each year for world class businesses.


Time of India
5 days ago
- Business
- Time of India
Samsung launches 'Big Celebration, Bigger Screen' deals for Independence Day: Avail deals and discounts on Samsung smart TV range
If you are planning to purchase a smart TV, then this may be the right time to do so. On the occasion of Independence Day Samsung has announced the launch of its 'Big Celebration, Bigger Screen' sale offering deals on its smart TV range. Running from August 1 to 31, the sale brings massive discounts, complimentary products, and flexible financing options to consumers looking to upgrade their home entertainment. Highlights of the offer include: Free soundbars worth up to Rs 92,990 with select TV purchases Complimentary TVs valued up to Rs 2,05,000 with high-end models Zero down payment and EMIs starting at Rs 2,990, with tenure up to 30 months Up to 20% cashback and an exclusive 10% extra cashback for Samsung Axis Bank credit card users Three-year extended warranty on select models Consumers can visit major online platforms, or nearby Samsung stores to explore these limited-time offers. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like No annual fees for life UnionBank Credit Card Apply Now Undo 'We want to make this Independence Day even more special by enabling families to upgrade to Samsung's AI-powered Big TVs,' said Viplesh Dang, senior director, Visual Display Business, Samsung India. 'Our goal is to democratize premium viewing experiences across India.' Samsung's Vision AI technology powers its latest lineup of Neo QLED, OLED, QLED, and Crystal 4K UHD TVs, offering: Intelligent picture and sound adjustments Personalized content recommendations Sleek, immersive design across 55-inch and larger screens AI Masterclass for Students. Upskill Young Ones Today!– Join Now


India.com
6 days ago
- Business
- India.com
Samsung Unveils Blockbuster Independence Day Offers on Vision AI TVs
Samsung India has launched its exciting Big Celebration, Bigger Screen offer this Independence Day and it will be held between August 1 and the last day of August i.e. 31st August, 2025. The campaign trains Indian buyers to upgrade their home cinemas with the league of Vision AI Big TVs by Samsung-which come now with a plus of amazing features. In the offer customers will get free gifts of up to 92990 (soundbars) or a TV (That is worth 205000) on purchase of select 55-inch and above models of the Neo QLED, OLED, QLED and also in the Crystal 4K UHD line-up. Moreover, Samsung is providing zero down payment option, EMIs as low as 2,990, interest free finance schemes of up to 30 months, and up to 20 percent cashback by major banks. The Samsung Axis Bank Credit Card gives their customers 10 percent additional cashback. The smart technology in the new Vision AI TVs will personalise pictures, sounds and contents depending on the preferences of the user, providing a cinematic experience at home. According to Viplesh Dang, Senior Director and Head of visual display business in Samsung India, the company wishes to make the current Independence Day special and thus operating to bring the Indian families closer to its premium AI-powered TVs. By these offers, Samsung stands to continue its belief in innovation and value. The consumers are able to access these blockbuster offers through the Samsung retail stores and also through It might be a night in with your favorite festive film or a big national day, now is the best time ever to have a smart bigger screen at home.


Cision Canada
29-07-2025
- Business
- Cision Canada
AI Just Got a Green Light from the White House--Here's What That Means for Healthcare Stocks
VANCOUVER, BC, July 29, 2025 /CNW/ -- Equity Insider News Commentary – There's a lot of big voices pushing for the AI revolution to make its mark, including a new plan from the U.S. Department of Commerce to address slow-to-adopt sectors like healthcare. The comes as part of US President Trump's paper, titled Winning the Race: AMERICA'S AI ACTION PLAN, which encourages setting up regulatory sandboxes, or regulation-free environments where AI can be tested in real world scenarios with heavy oversight. As the market evaluates the opportunities available, several tech and biotech companies are already moving towards major milestones in AI-powered healthcare solutions, including Avant Technologies, Inc. (OTCQB: AVAI), Renovaro Inc. (NASDAQ: RENB), Healthcare Triangle, Inc. (NASDAQ: HCTI), GE HealthCare Technologies Inc. (NASDAQ: GEHC), and Spectral AI, Inc. (NASDAQ: MDAI). According to Accenture, AI could inject an additional $461 billion into the healthcare sector by 2035, as it surpasses the $2.26 trillion mark. Now, as AI makes its move into the healthcare space, experts are working to help guide these new solutions towards being more accurate, in a space where AI's inaccuracies (known as "hallucinations") are not an option. Thankfully, there are several players making important advancements in diagnostics, drug development, and workflow, through the use of AI. Avant Technologies, Inc. (OTCQB: AVAI) and joint-venture partner Ainnova Tech have taken a key regulatory step forward by finalizing an updated clinical trial protocol for their AI-powered Vision AI platform, following formal feedback from a mid-July pre-submission meeting with the FDA. The revised protocol, which addresses the FDA's comments, has now been presented to Fortrea, the company's contract research organization, for review. Once approved, the protocol will enable the launch of a new U.S.-based clinical trial designed to support Ainnova's goal of obtaining FDA 510(k) clearance for Vision AI in the early detection of diabetic retinopathy. "We are committed to meeting the highest regulatory standards, and we're confident that these protocol refinements will strengthen our path toward FDA 510(k) clearance," said Vinicio Vargas, CEO at Ainnova and a member of the Board of Directors of Ai-nova Acquisition Corp. (AAC), the company formed by the partnership between Avant and Ainnova to advance and commercialize Ainnova's technology portfolio. "We anticipate finalizing the clinical trial budget soon, with estimated costs coming more into focus as we refine our protocol and navigate the process." The U.S. regulatory push builds on expanding visibility for Vision AI across Latin America. In June, Vargas was featured at Roche's"Macular Spectacular" Ophthalmology Conference in Cartagena, Colombia, where he presented Vision AI as a cost-effective screening tool that can prevent diabetic blindness and improve health access in low-resource settings. He also highlighted a Q4 2024 pilot with Roche and Salud 360 that could scale across the U.S., Canada, and Europe if successful. Meanwhile, Vision AI has gone live through Grupo Dökka's Fischel and La Bomba pharmacy chains, offering walk-in screenings, real-time AI results, and direct referrals to care providers. The model eliminates the need for onsite ophthalmologists and is gaining traction with pharmacy chains, insurers, and life sciences partners. Avant and Ainnova's FDA engagement follows an earlier pre-submission meeting in July, where the agency provided clear guidance on study design and compliance. The refined clinical trial protocol, once greenlit, will guide a formal U.S. study aimed at supporting FDA clearance to market Vision AI domestically. Avant maintains global licensing rights to Ainnova's platform through Ai-nova Acquisition Corp., the JV established to commercialize Ainnova's technology portfolio. U.S. entry is viewed as a major inflection point with significant commercial potential. Looking ahead, Vision AI could serve as a frontline tool for broader disease detection. Ainnova's future roadmap includes a cloud-connected retinal camera for rural clinics and new modules aimed at identifying Alzheimer's, cardiovascular conditions, and other chronic diseases through retinal or blood biomarkers. Avant has also signaled plans for a dedicated therapeutic-focused spinout and continues to evaluate a full acquisition of Ainnova Tech under a previously announced non-binding LOI—potentially consolidating all assets and leadership under a single public platform. Renovaro Inc. (NASDAQ: RENB) secured multiple U.S. patents for its federated AI learning technologies in biomedical research. "Expanding our IP footprint in federated learning and AI-based data harmonization directly supports our long-term vision: to be the platform of choice for next-generation biomedical research and precision medicine," said David Weinstein, CEO, Renovaro. These patents support secure, privacy-preserving data integration across hospitals and labs for applications in drug discovery and precision medicine. The move strengthens Renovaro's position in the $20 billion biomedical AI space. Healthcare Triangle, Inc. (NASDAQ: HCTI) recently signed major contracts with large U.S. hospital systems and expanded its AI-powered EHR services. Its platform converts unstructured medical documents into usable data for clinicians. "These strategic wins reflect our ability to deliver enterprise-scale transformation with speed and precision," said Sujatha Ramesh, Chief Operating Officer of Healthcare Triangle." We're driving digital maturity, operational efficiency, and cost-effective care delivery - firmly positioning HCTI as a mission-critical partner, not just a service provider." The company is focused on making EHR systems smarter, more efficient, and better suited to community health networks. GE HealthCare Technologies Inc. (NASDAQ: GEHC) launched its Definium Pace Select ET, an AI-powered digital X-ray system for high-volume medical settings. "This launch reinforces our commitment to provide accessible, efficient, and high-quality care for patients, while alleviating stress from the technologist's workday by minimizing repetitive tasks and automating steps," said Jyoti Gupta, PhD, President and CEO of Women's Health and X-ray at GE HealthCare. "We remain dedicated to advancing our technology through transformative digital and AI-enabled capabilities that will remove barriers to timely and effective diagnostic imaging for any patient in need of X-ray imaging." The system automates repetitive tasks and improves image consistency to help radiologists work more efficiently. It's designed to relieve staffing pressures while maintaining high imaging standards in busy hospitals. Spectral AI, Inc. (NASDAQ: MDAI) submitted its DeepView System to the FDA for marketing approval under the De Novo pathway. "This FDA submission is a major milestone for Spectral AI and the DeepView System, representing a crucial step toward bringing this innovative diagnostic device to market in the United States," said Dr. J. Michael DiMaio, MD, Chairman of the Board at Spectral AI. "It provides clinicians with an immediate, data-driven assessment tool designed to assist clinical decision-making and may significantly improve patient outcomes." The device uses multispectral imaging and AI to predict how burn wounds will heal, helping doctors make faster and more accurate treatment decisions. It's positioned as a first-of-its-kind diagnostic tool in burn care. DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Equity Insider is a wholly-owned subsidiary of Market IQ Media Group, Inc. ("MIQ"). MIQ has been paid a fee for Avant Technologies Inc. advertising and digital media from the company directly. There may be 3rd parties who may have shares Avant Technologies Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ own shares of Avant Technologies Inc. which were purchased in the open market. MIQ reserves the right to buy and sell, and will buy and sell shares of Avant Technologies Inc. at any time thereafter without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material disseminated by MIQ has been approved by the above mentioned company; this is a paid advertisement, and we own shares of the mentioned company that we will sell, and we also reserve the right to buy shares of the company in the open market, or through other investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.